Researchers at The University of Manchester have discovered that a potential new drug reduces the number of brain cells destroyed by stroke and then helps to repair the damage.
A reduction in blood flow to the brain caused by stroke is a major cause of death and disability, and there are few effective treatments.
A team of scientists at The University of Manchester has now found that a potential new stroke drug not only works in rodents by limiting the death of existing brain cells but also by promoting the birth of new neurones (so-called neurogenesis).
This finding provides further support for the development of this anti-inflammatory drug, interleukin-1 receptor antagonist (IL-1Ra in short), as a new treatment for stroke. The drug is already licensed for use in humans for some conditions, including rheumatoid arthritis. Several early stage clinical trials in stroke with IL-1Ra have already been completed in Manchester, though it is not yet licensed for this condition.
In the research, published in the biomedical journal Brain, Behavior and Immunity, the researchers show that in rodents with a stroke there is not only reduced brain damage early on after the stroke, but several days later increased numbers of new neurones, when treated with the anti-inflammatory drug IL-1Ra.
Previous attempts to find a drug to prevent brain damage after stroke have proved unsuccessful and this new research offers the possibility of a new treatment.
Importantly, the use of IL-1Ra might be better than other failed drugs in stroke as it not only limits the initial damage to brain cells, but also helps the brain repair itself long-term through the generation of new brain cells.
The results lend further strong support to the use of IL-1Ra in the treatment of stroke, however further large trials are necessaryProfessor Stuart Allan
These new cells are thought to help restore function to areas of the brain damaged by the stroke. Earlier work by the same group showed that treatment with IL-1Ra does indeed help rodents regain motor skills that were initially lost after a stroke. Early stage clinical trials in stroke patients also suggest that IL-1Ra could be beneficial.
The Latest on: Stroke treatment
via Google News
The Latest on: Stroke treatment
- Elderly husband of 73-year-old Indian woman who gave birth to twins suffers strokeon September 6, 2019 at 10:15 pm
But just a day after his daughters were born, Rajarao suffered a stroke and is currently being treated in hospital. The birth has raised questions over whether doctors should be providing IVF ...
- Indian woman, 74, gives birth to twins after IVF treatmenton September 6, 2019 at 5:14 pm
Doctors delivered the twins, who were born following IVF treatment, on Thursday ... However, a day later, Mr Rajarao suffered a sudden stroke and is currently being treated in hospital.
- The Rite Care Clinic at St. Ambrose offers patients free speech pathology treatment while it trains future clinicianson September 6, 2019 at 1:00 pm
After he had the stroke, he could only speak one word, and the right side of his face was numb, making it hard to swallow pills. After eight years of treatments at the St. Ambrose University Rite ...
- NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Strokeon September 6, 2019 at 7:07 am
This study is intended to provide the data to expand the indication in the United States to include "PFO Closure for the Reduction of Recurrent Ischemic Stroke". The NobleStitch ... part of structural ...
- Column: Medicaid expansion right treatment for NC's rural hospitalson September 5, 2019 at 12:00 pm
Medicaid expansion could, in one stroke, profoundly improve the physical and economic health of rural communities. Expansion would ensure lifesaving care for hundreds of thousands of North Carolinians ...
- High quality stroke care at Metro Healthon September 4, 2019 at 9:32 am
That’s why Metro Health takes pride in constantly adding expertise in stroke treatment advancement recognized with their certification as a Comprehensive Stroke Center. This year’s VITALity Gala is ...
- NIH trial aims to improve drug discovery for ischemic strokeon September 4, 2019 at 8:50 am
The National Institutes of Health (NIH) has announced it will fund a nationwide preclinical trial platform called the Stroke Preclinical Assessment Network (SPAN) to ensure candidate new treatments ...
- Possible stroke treatment breakthroughon September 4, 2019 at 1:50 am
A new drug to kill blood clots could be tested on patients within months and if successful it could become a breakthrough in stroke treatments. A new drug to kill blood clots could be tested on ...
- Neurotechnology-aided Interventions for Upper Limb Motor Rehabilitation in Severe Chronic Strokeon September 2, 2019 at 9:17 pm
We encourage the identification of objective biomarkers for stroke recovery for patients' stratification and to tailor treatments. Furthermore, the advantage of longitudinal personalized trial designs ...
via Bing News